Sanofi-Aventis/Altana's Asthma Therapy Alvesco Is "Approvable"

FDA says the review decision came directly from ODE II rather than the Division of Pulmonary & Allergy Drug Products. Aventis had touted Alvesco as one of six product launches that would drive organic growth during its attempts to fend off Sanofi's merger bid.